New research suggests that biological therapies (biologics) do not increase the risk of recurrent cancer compared to conventional disease modifying anti-rheumatic drugs (DMARDs). The study, which will be presented at Rheumatology 2014, analysed data from almost 19,000 patients with rheumatoid arthritis.
More...
More...